IceCure Medical (ICCM) Cash from Investing Activities (2020 - 2026)
IceCure Medical (ICCM) posted quarterly Cash from Investing Activities of -$51000.0 for Q1 2026, down 750.0% year-over-year from $7846.2 in Q1 2025, and down 101.02% quarter-over-quarter from $5.0 million in Q4 2025.
IceCure Medical (ICCM) Cash from Investing Activities (2020 - 2026) Analysis & Trends
IceCure Medical (ICCM) has reported Cash from Investing Activities for 7 consecutive years, with -$51000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash from Investing Activities fell 750.0% year-over-year to -$51000.0; the TTM figure through Mar 2026 stood at -$81000.0 (down 58.82% YoY), while the FY2025 annual figure was -$36000.0, down 108.07% from the prior year.
- Cash from Investing Activities eased to -$51000.0 in Q1 2026 per ICCM's latest filing, from $5.0 million in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $8.7 million in Q4 2023 and bottomed at -$15.1 million in Q1 2023.
- Historically, Cash from Investing Activities has averaged -$71529.4 across 5 years, with a median of -$6000.0 in 2025.
- Annual changes were most pronounced in 2023 — Cash from Investing Activities slumped 10400.0% — and 2025, when it soared 71457.14%.
- IceCure Medical's Cash from Investing Activities stood at $1.7 million in 2022, then soared by 419.99% to $8.7 million in 2023, then tumbled by 100.08% to -$7000.0 in 2024, then jumped by 71457.14% to $5.0 million in 2025, then plunged by 101.02% to -$51000.0 in 2026.
- Business Quant data shows ICCM's Cash from Investing Activities at -$51000.0 in Q1 2026, $5.0 million in Q4 2025, and -$5.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn | -639.00 Mn |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn | -1.96 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | -193.20 Mn |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn | 329.80 Mn |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn | -115.00 Mn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | -22.08 Mn |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn | -108.50 Mn |
| 10 | IceCure Medical | 6.77 Mn | -5.26 Mn | 253,000.00 | -10,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -10,000.00 |
| Jun 30, 2026 | -10,000.00 |
| Mar 31, 2026 | -51,000.00 |
| Mar 31, 2026 | -51,000.00 |
| Dec 31, 2025 | 5.00 Mn |
| Dec 31, 2025 | 5.00 Mn |
| Sep 30, 2025 | -5.00 Mn |
| Sep 30, 2025 | -5.00 Mn |
| Jun 30, 2025 | -22,000.00 |
| Jun 30, 2025 | -22,000.00 |
| Mar 31, 2025 | -6,000.00 |
| Mar 31, 2025 | -6,000.00 |
| Dec 31, 2024 | -7,000.00 |
| Dec 31, 2024 | -7,000.00 |
| Sep 30, 2024 | 805,000.00 |
| Sep 30, 2024 | 805,000.00 |
| Jun 30, 2024 | -843,000.00 |
| Jun 30, 2024 | -843,000.00 |
| Mar 31, 2024 | 491,000.00 |
| Mar 31, 2024 | 491,000.00 |